Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: United Therapeutics Corporation, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
United Therapeutics Corporation June 26, 202691.2%
-
United Therapeutics Corporation June 26, 202594.5%
-
United Therapeutics Corporation June 26, 202495.4%
-
United Therapeutics Corporation June 26, 202395.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 9, 2026 | United Therapeutics Corporation | Option exercise | +1,310 | — | — |
| Jul 25, 2025 | United Therapeutics Corporation | Option exercise | +1,190 | — | — |
| Jun 24, 2025 | United Therapeutics Corporation | Option exercise | +5,000 | $175.43 | $877,150 |
| Jun 24, 2025 | United Therapeutics Corporation | Open-market sale | −3,036 | $289.60 | $879,226 |
| Nov 5, 2024 | United Therapeutics Corporation | Option exercise | +10,000 | $175.43 | $1,754,300 |
| Nov 5, 2024 | United Therapeutics Corporation | Open-market sale | −8,571 | $381.61 | $3,270,779 |
| Nov 5, 2024 | United Therapeutics Corporation | Open-market sale | −1,429 | $382.28 | $546,278 |
| Jul 13, 2024 | United Therapeutics Corporation | Option exercise | +1,800 | — | — |
| Mar 6, 2024 | United Therapeutics Corporation | Option exercise | +10,000 | $88.03 | $880,300 |
| Mar 6, 2024 | United Therapeutics Corporation | Sold back to the company | −10,000 | $236.97 | $2,369,700 |
| Dec 1, 2023 | United Therapeutics Corporation | Option exercise | +5,000 | $88.03 | $440,150 |
| Dec 1, 2023 | United Therapeutics Corporation | Sold back to the company | −5,000 | $240.73 | $1,203,650 |
| Jul 7, 2023 | United Therapeutics Corporation | Option exercise | +1,750 | — | — |
| May 22, 2023 | United Therapeutics Corporation | Option exercise | +5,000 | $63.90 | $319,500 |
| May 22, 2023 | United Therapeutics Corporation | Sold back to the company | −5,000 | $218.59 | $1,092,950 |
Questions about Richard Giltner
What boards is Richard Giltner on?
Richard Giltner sits on the board of United Therapeutics Corporation.
How long has Richard Giltner served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.